Motivating a Spectrum of Cancer Patients to Quit Smoking
Study Details
Study Description
Brief Summary
This study will assess feasibility and acceptability of an intervention designed to increase smoking cessation motivation among patients with a cancer not widely known to be smoking related.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Self Help Materials Participants will receive a smoking cessation booklet/pamphlet corresponding to their cancer type. |
Behavioral: Self-help Materials
Self-help booklet targeted by cancer type to increase smoking cessation motivation
|
Outcome Measures
Primary Outcome Measures
- Number of participants who consent to participate in the study- Feasibility [Baseline]
Number of participants who consent to participate in the study
- Number of participants that complete 1-week follow-up assessments - Feasibility [1-week post-treatment]
Number of participants who complete 1-week follow-up assessments
- Number of participants that complete 1 month follow-up assessments - Feasibility [1-month post-treatment]
Number of participants who complete 1-month follow-up assessments
- Demand - 1 Week Post Treatment [1-week post-treatment]
Number of study participants who read the booklet
- Demand - 1 Month Post Treatment [1-month post-treatment]
Number of study participants who read the booklet
- Acceptability [1-month post-treatment]
Treatment satisfaction measured with 8 items adapted from the Client Satisfaction Questionnaire
Secondary Outcome Measures
- Motivation to quit smoking assessed with the Contemplation Ladder [Baseline, 1-week post-treatment, 1-month post-treatment]
Changes in motivation to quit smoking will be assessed using the Contemplation Ladder. This is a validated measure for the assessment of readiness to quit smoking on a scale from 0 to 10. Higher scores indicate greater motivation to quit smoking.
- Motivation to quit smoking assessed with the short form of the smoking abstinence-related motivational engagement (ARME). [Baseline, 1-week post-treatment, 1-month post-treatment]
Changes in motivation to quit smoking will be assessed using the short form of the smoking abstinence-related motivational engagement (ARME), which is a valid and reliable measure of cessation motivation that includes 5 items related to the smokers' daily experience ranging from 1 (completely disagree) to 7 (completely agree). Higher scores indicate greater motivation to quit smoking.
- Motivation to quit smoking assessed with the Stages of Change Algorithm (SOC) [Baseline, 1-week post-treatment, 1-month post-treatment]
Changes in motivation to quit smoking will be assessed using the Stages of Change algorithm (SOC). This is a widely used measure for the assessment of readiness to quit smoking.
- Motivation to quit smoking assessed with the number of visits to the study website [1-month post-treatment]
A personal code will be able to track the number of participants who visited the study website where participants will find existing smoking cessation resources. This will be considered a behavioral indicator of motivation to quit smoking.
- Motivation to quit smoking assessed by contact with the tobacco treatment specialist [1-week post-treatment, 1-month post-treatment]
Participants will be asked if they have contacted the tobacco treatment specialist or if they would like us to make a referral for them. This will be considered a behavioral indicator of motivation to quit smoking.
- Motivation to quit smoking assessed with the number of quit attempts [1-week post-treatment, 1-month post-treatment]
One item will assessed if participants had a quit attempt that lasted at least 24 hours (at the 1-week assessment) and how many times participants quit smoking in the last 30 days (at the 1-month assessment).
- Motivation to quit smoking assessed with the number of quit attempts at 1 week [1-week post-treatment]
Number of participants that had a quit attempt that lasted at least 24 hours at the 1-week assessment and how many times participants quit smoking in the last 30 days (at the 1-month assessment).
- Motivation to quit smoking assessed with the number times participants quit smoking [1-month post-treatment]
Number times participants quit smoking in the last 30 days (at the 1-month assessment).
- Biochemically confirmed 7-day Point Prevalence Abstinence [1-week post-treatment]
Smoking abstinence will be determined by a self-report of not smoking in the last 7 days and by a result of ≤5ppm in carbon monoxide breath testing.
- Biochemically confirmed 30-day Point Prevalence Abstinence [1-month post-treatment]
Smoking abstinence will be determined by a self-report of not smoking in the last 30 days and by a result of ≤5ppm in carbon monoxide breath testing.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Smoking at least 1 cigarette in previous 30 days
-
Diagnosis of breast, colorectal, gynecological, skin melanoma, or bladder cancer within the last 6 months
-
Able to read/write English
-
Able to give informed consent
-
Not currently enrolled in a smoking cessation program
Exclusion Criteria:
-
Having distant metastases
-
Male patients with breast cancer
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Moffitt Cancer Center | Tampa | Florida | United States | 33612 |
Sponsors and Collaborators
- H. Lee Moffitt Cancer Center and Research Institute
- National Cancer Institute (NCI)
Investigators
- Principal Investigator: Ursula Martinez, Ph.D., Moffitt Cancer Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- MCC-19733
- 1R03CA227044-01A1